Glibenclamide News and Research

RSS
Glibenclamide is an anti-diabetic drug in a class of medications known as sulfonylureas.
Metformin for diabetics with renal damage scores over Sulphonylureas in terms of heart safety

Metformin for diabetics with renal damage scores over Sulphonylureas in terms of heart safety

Risk of hypoglycemia differs between SU agents, study reveals

Risk of hypoglycemia differs between SU agents, study reveals

Innovative treatment may help prevent brain swelling, death in stroke patients

Innovative treatment may help prevent brain swelling, death in stroke patients

A new approach to TBI therapy

A new approach to TBI therapy

IQWiG dossier assessment finds no added benefit of lixisenatide

IQWiG dossier assessment finds no added benefit of lixisenatide

No added benefit from linagliptin in patients with type 2 diabetes

No added benefit from linagliptin in patients with type 2 diabetes

Metabolic stress can increase onset of atrial fibrillation

Metabolic stress can increase onset of atrial fibrillation

Study examines role of NLRP3 inflammasome in ventilator-induced lung injury

Study examines role of NLRP3 inflammasome in ventilator-induced lung injury

Linagliptin does not offer added benefit for adults with type 2 diabetes

Linagliptin does not offer added benefit for adults with type 2 diabetes

Patients with type 2 diabetes can benefit from metformin than other drugs

Patients with type 2 diabetes can benefit from metformin than other drugs

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

Comprehensive review on sulfonylureas in the latest issue of Diabetic Hypoglycemia

Comprehensive review on sulfonylureas in the latest issue of Diabetic Hypoglycemia

Diabetic medication 'glibenclamide' may prevent nicotine-induced SIDS

Diabetic medication 'glibenclamide' may prevent nicotine-induced SIDS

Regulatory agency alerts consumers about poor quality of some traditional chinese medicines

Regulatory agency alerts consumers about poor quality of some traditional chinese medicines